Stocks are looking to shake off yesterday's setback and continue their hot streak... January 10, 2024 | [Read Online]( Chris Dinello
January 10, 2024 Good Morning! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Let's get ready to trade! Markets ð The market stumbled on Tuesday despite a hot start to the trading week. The Nasdaq was the dayâs loan gainer with a minimal advance. - S&P 500 [-0.1%] - Dow [-0.4%] - Nasdaq [<0.1%] - Russell 2K [-1.0%] Futures are down again this morning, albeit by a thin margin. S&P contracts are holding steady with a loss of less than 0.1% at the moment. [The Most Overlooked Gold Play for 2024?]( There is little debate on the potential of gold in the next year and decade. The real question becomes - what's the best gold investment strategy today? Some investors are opting for a unique "royalty" alternative that outshines other options like holding gold bullion or investing in volatile mining stocks. [Get a Full Briefing on the Best Opportunities Here]( Premarket Highlights ð FAKE NEWS: The SEC posted this image on its X account after it was hacked. 𤣠AMATUER HOUR: SECâs X Account Gets Hacked An unauthorized user gained access to the Securities Exchange Commissionâs X account late Tuesday, and hilarity ensued. The hack became obvious after the SEC account published a post claiming it had approved Bitcoin ETFs for âall registered national security exchanges.â BTC prices jumped past $43,000 on the news, but SEC Commissioner Gary Gensler quickly intervened on X and put the rumor to rest. Gensler called the post âunauthorizedâ and reiterated the regulator had yet to approve any form of Bitcoin ETF. Trolled ðº
Xâs Safety team also chimed in on the matter, noting that the hack wasnât the result of a failure in its systems. SHOTS FIRED: Elon Muskâs X team says, donât blame us, and explains the hack was the result of the SEC accountâs poor cybersecurity practices. An official representative from the SEC confirmed that their X account experienced unauthorized access for a short duration post-4 p.m. The agency said its working with law enforcement to investigate the breach and determine appropriate actions. Following the SEC's rectification, Bitcoin's value dipped under $46,000. Bitcoin ETF on Deck? ð
Investors in the cryptocurrency market have been keenly awaiting the SEC's approval for spot bitcoin ETFs from major asset management firms like BlackRock and Fidelity Investments. This anticipation has built up over more than ten years, and the regulator is expected to announce a key decision on spot Bitcoin ETFs as soon as today. Many market watchers and crypto enthusiasts are optimistic about the likelihood of approval, citing recent intense interactions involving SEC staff, ETF providers, and exchanges to finalize operational aspects of these funds. Yesterdayâs âannouncementâ wasnât legit, but the real thing could be coming soon. Until then, the SEC should probably activate 2FA on its X account. ð What to Watch Today ð Followup to Yesterdayâs Slide
The stock market came out of the gate swinging this week, but its run was cut short on Tuesday. Today, weâll see if the market continues to face resistance, or if it can regain its form. Right now, the S&P 500 and Dow are having difficulty smashing through to new highs, and it could take a notable catalyst to get past the resistance. The performance in todayâs session could provide valuable insights into the current state of investor confidence. Featured Earnings ð² - KB Home [KBH] ... PM - Richardson Electronics [RELL] ... PM Economy ð - Wholesale inventories [Nov] ... 10:00a Running Hot ð¥ Gainers - NVNI Grp. [NVNI] >> +58.5% - Jin Medical [ZJYL] >> +25.6% - Spruce [SPRB] >> +13.3% Decliners - Aehr Test Systems [AEHR] >> (18.4%) - Aclaris Therapeutics [ACRS] >> (17.9%) - Sensei Biotherapeutics [SNSE] >> (11.2%) Clearmind Medicine [CMND] - Last Close: $2.07 The psychedelic pharma stock just announced the completion of a Type A meeting with the Food & Drug Administration for CMND-100. In the meeting, the two sides discussed a regulatory path forward for the drug candidate as a treatment for Alcohol Use Disorder. Clearmind CEO Adi Zuloff-Shani said the meet was âinformative and productive,â and his company is âeager to advance the regulatory process.â CMND is a top mover with a 47.8% gain on more than 10 million shares traded this morning, so far. My Take: CMND was riding high a few months ago, but itâs down big since then. Howver, shares could rebound quickly if this drug candidate gets back on the right track. Exicure [XCUR] - Last Close: $0.6201 This morning, this early-stage biotech announced it was granted a broad U.S. patent for one of its drug developments. The title of the newly issued patent is, â"Liposomal Nucleic Acid Constructs Presenting Antisense Oligonucleotides For Knockdown Of Interleukin 17 mRNA (For Inflammation From Cancer, Obesity, Diabetes, Alzheimer's)" News of the patent is quickly boosting the tiny stock. Itâs currently up 29.6% on nearly 5 million shares traded. My Take: XCUR is a tiny stock with an elevated short ratio, so I suspect we could seee a pullback soon. iCoreConnect [ICCT] - Last Close: $1.30 This healthcare technology stock landed a deal to acquire Verifi Dental for an undisclosed amount. CEO Robert McDermott said, âThis strategic acquisition signifies positive momentum for the Company and the advancement of our growth strategy.â Over the past few weeks, iCoreConnect has also announced deals to acquire Teamworx Dental and FeatherPay. ICCT is a top mover with an 11.5% gain on more than 4 million shares traded. My Take: ICCT appears to be on a shopping spree, but only time will tell if this strategy will pay off. Amarin Corp. [AMRN] - Last Close: $0.9709 This pharma stock is heating up after publishing preliminary Q4 2024 financials and outlining its key priorities for 2024. Most notably, the company announced plans to launch a $50 million share buyback program in the coming months. Amarin also said it expects to post revenues in the range of $72 million to $74 million in Q4, beating its previously issued guidance of $62 million. AMRN is up 15.3% on nearly a million shares traded in the premarket. My Take: AMRN has been locked in a clear up-trend since the start of December, although it has seen some volatility within its trading range. Share prices could find support at the $1 mark if it can hold onto its gains. That's it for today! Thanks for reading, and good luck out there! Best Regards, â Chris D.
Elite Trade Club Text ELITE to 47121 or [click here](Â to get our alerts on your mobile device, and never miss another fast-moving stock! P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP. [Sign up for SMS]( Join Elite Growth Stocks for instant access to this report. [Get Instant Access Now]( [tw]( [ig]( [yt]( [tk]( *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails. [Privacy Policy]( | [Terms of Service]( Update your email preferences or unsubscribe [here]( © 2024 Elite Trade Media LLC 1969 Alafaya Tr., Suite #247
Orlando, Florida 32828, United States of America